Artikel
The role of Triamcinolone Acetonide (TA) in controlling postoperative inflammation following uncomplicated cataract surgery (K)
Suche in Medline nach
Autoren
Veröffentlicht: | 5. Mai 2014 |
---|
Gliederung
Text
Purpose: To evaluate applying 1 mg TA in the AC in controlling ocular inflammation in patients undergoing cataract surgery (SICS).
Methods: 50 eyes of 50 patients undergoing elective SICS (small incision cataract surgery) with IOL implantation (PMMA) lens were were randomized into two groups. Some cases had PEX Syndrome, insufficiently dilated pupil, or hazy cornea which led for incomplete cortex removal. After surgery, group A were administered intracameral 1 mg/ 0.1 ml TA, group B were not. Postoperatively; in group B, topical prednisolone acetate 1% eyedrops were administered Q2h while awake for 1wk, then tapered within 6wk. In group A, the same topical corticosteroids were used with the same time and frequency. To evaluate the efficacy of TA, AC cells were measured on postoperative days 1,7,30,60, and 90 by slit-lamp biomicroscopy.Safety was evaluated by IOP values.
Results: TA was more effective in controlling postoperative inflammation especially in cases of cortical remains. No statistically significant differences between groups were observed for IOP values, and no serious adverse events were observed.
Conclusions: Triamcenelone acetonide of 1 mg can effectively be used to control postoperative inflammation after uncomplicated cataract surgery with SICS especially if some cortex was not removed completely.